Influence of continuous subcutaneous apomorphine infusion on cognition and behavior in Parkinson's disease: A systematic review.

Autor: Houvenaghel JF; Department of Neurology, Rennes University Hospital, CIC Inserm 1414, 35033 Rennes, France. Electronic address: jeanfrancois.houvenaghel@chu-rennes.fr., Meyer M; Department of Neurology, Nancy University Hospital, 54000 Nancy, France., Schmitt E; Division of Neurology, Grenoble Institute of Neuroscience, CHU de Grenoble-Alpes, Grenoble-Alpes University, Inserm U1216, 38700 Grenoble, France., Arifi A; Department of Neurology, Montpellier University Hospital, 34090 Montpellier, France., Benchetrit E; Department of Neurology and Movement Disorders, Parkinson Expert Center, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, 13005 Marseille, France., Bichon A; Division of Neurology, Grenoble Institute of Neuroscience, CHU de Grenoble-Alpes, Grenoble-Alpes University, Inserm U1216, 38700 Grenoble, France., Cau C; Department of Neurology, Pays d'Aix Hospital Center, 13100 Aix-en-Provence, France., Lavigne L; Department of Neurology, Nancy University Hospital, 54000 Nancy, France., Le Mercier E; Department of Neurology, Caen University Hospital, 14000 Caen, France., Czernecki V; Department of Neurology, Paris Brain Institute-ICM, Salpêtrière Hospital, Assistance publique-Hôpitaux de Paris, Sorbonne université, Inserm, 75013 Paris, France., Dujardin K; Neurology and Movement Disorders Department, NS-Park/F-CRIN, Lille Neurosciences and Cognition, CHU de Lille, University Lille, Inserm, 59000 Lille, France.

Publikováno v: Revue neurologique [Rev Neurol (Paris)] 2024 Aug 06. Date of Electronic Publication: 2024 Aug 06.

Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical Modifications.

Autor: Devignes Q; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France., Daoudi S; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France., Viard R; Univ. Lille, CNRS, Inserm, US 41 - UMS 2014 - PLBS, CHU Lille, Lille Pasteur Institute, Lille, France., Lopes R; Univ. Lille, CNRS, Inserm, US 41 - UMS 2014 - PLBS, CHU Lille, Lille Pasteur Institute, Lille, France., Betrouni N; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France., Kuchcinski G; Univ. Lille, CNRS, Inserm, US 41 - UMS 2014 - PLBS, CHU Lille, Lille Pasteur Institute, Lille, France., Rolland AS; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Department of Medical Pharmacology, NS-Park/F-CRIN, Lille, France., Moreau C; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France., Defebvre L; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France., Bardinet E; Institut du Cerveau (ICM), Centre de Neuro-Imagerie de Recherche (CENIR), UMR S 1127, CNRS UMR 7225, Sorbonne Université, Paris, France., Bonnet M; Centre Expert Parkinson, NS-Park/F-CRIN, Centre Mémoire de Ressources et de Recherche, IMNc, Hôpital Pellegrin, CHU de Bordeaux, France., Brefel-Courbon C; Service de Neurologie B8, Centre Expert Parkinson, NS-Park/F-CRIN, Hôpital Pierre Paul Riquet, CHU Purpan, Toulouse, France., Delmaire C; Department of Radiology, NS-Park/F-CRIN, Hôpital Fondation A de Rothschild, Paris, France., El Mountassir F; Université Paris-Saclay, CEA, CNRS, Baobab, Neurospin, Gif-sur-Yvette, France and Institut du Cerveau (ICM), UMR S 1127, CNRS UMR 7225, Sorbonne Université, Paris, France., Fluchère F; Department of Neurology, NS-Park/F-CRIN, Assistance Publique - Hôpitaux de Marseille (APHM), Timone University Hospital and Institut de Neurosciences de la Timone, Marseille, France., Fradet A; Neurology Department, NS-Park/F-CRIN, University Hospital of Poitiers and INSERM, University of Poitiers, Centre d'Investigation Clinique CIC 1402, Poitiers, France., Giordana C; Department of Neurology, NS-Park/F-CRIN, Centre Hospitalier Universitaire de Nice, Nice, France., Hainque E; Sorbonne Université, Paris Brain Institute - ICM, NS-Park/F-CRIN, Assistance publique Hôpitaux de Paris, Inserm, CRNS, Hôpital Pitié-Salpêtrière, Department of Neurology, Paris, France., Houvenaghel JF; Department of Neurology, NS-PARK/F-CRIN, University Hospital of Rennes, Rennes, France., Jarraya B; Neuroscience Pole, NS-Park/F-CRIN, Hôpital Foch, Suresnes, University of Versailles Paris-Saclay, INSERM-CEA NeuroSpin, Saclay, France., Klinger H; Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, NS-Park/F-CRIN, Lyon, France., Maltête D; Department of Neurology, NS-Park/F-CRIN, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France., Marques A; Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, NS-Park/F-CRIN, Clermont-Ferrand, France., Meyer M; Neurology department, NS-Park/F-CRIN, Central Hospital, CHRU-Nancy, Nancy, France., Rascol O; Department of Clinical Pharmacology and Neuroscience, NS-Park/F-CRIN, Toulouse University Hospital, Toulouse, France., Rouaud T; Department of Neurology, Centre Expert Parkinson, NS-Park/F-CRIN, CHU Nantes, Nantes, France., Tir M; Department of Neurology, NS-PARK/FCRIN, Amiens University Hospital, Amiens, France., Wirth T; Service de Neurologie, NS-Park/F-CRIN, Hôpitaux Universitaires de Strasbourg et Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France.; Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France., Corvol JC; Sorbonne Université, Paris Brain Institute - ICM, NS-Park/F-CRIN, Assistance publique Hôpitaux de Paris, Inserm, CRNS, Hôpital Pitié-Salpêtrière, Department of Neurology, Paris, France., Devos D; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France.; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Department of Medical Pharmacology, NS-Park/F-CRIN, Lille, France., Dujardin K; Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France.

Publikováno v: Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (5), pp. 1507-1526.

Functional Role of the Cerebellum in Parkinson Disease: A PET Study.

Autor: Riou A; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France. audrey.riou@chu-rennes.fr., Houvenaghel JF; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Dondaine T; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Drapier S; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Sauleau P; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Drapier D; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Duprez J; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Guillery M; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Le Jeune F; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Verin M; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France., Robert G; From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France.

Publikováno v: Neurology [Neurology] 2021 Jun 08; Vol. 96 (23), pp. e2874-e2884. Date of Electronic Publication: 2021 Apr 28.

Subthalamic nucleus oscillations during vocal emotion processing are dependent of the motor asymmetry of Parkinson's disease.

Autor: Benis D; Clinical and Experimental Neuropsychology Laboratory, Department of Psychology and Educational Sciences, University of Geneva, Switzerland; Neuroscience of Emotion and Affective Dynamics laboratory, Department of Psychology and Swiss Center for Affective Sciences, Campus Biotech, University of Geneva, Switzerland; Swiss Center for Affective Sciences, Campus Biotech, University of Geneva, Switzerland., Haegelen C; Neurosurgery Department, Pontchaillou Hospital, Rennes University Hospital, France; INSERM, LTSI U1099, Faculty of Medicine, University of Rennes, France., Voruz P; Clinical and Experimental Neuropsychology Laboratory, Department of Psychology and Educational Sciences, University of Geneva, Switzerland., Pierce J; Clinical and Experimental Neuropsychology Laboratory, Department of Psychology and Educational Sciences, University of Geneva, Switzerland., Milesi V; Neuroscience of Emotion and Affective Dynamics laboratory, Department of Psychology and Swiss Center for Affective Sciences, Campus Biotech, University of Geneva, Switzerland; Swiss Center for Affective Sciences, Campus Biotech, University of Geneva, Switzerland., Houvenaghel JF; Neurology Department, Pontchaillou Hospital, Rennes University Hospital, France; Behavior and Basal Ganglia's research unit (EA 4712), University of Rennes 1, Rennes University Hospital, France., Vérin M; Neurology Department, Pontchaillou Hospital, Rennes University Hospital, France; Behavior and Basal Ganglia's research unit (EA 4712), University of Rennes 1, Rennes University Hospital, France., Sauleau P; Neurology Department, Pontchaillou Hospital, Rennes University Hospital, France; Behavior and Basal Ganglia's research unit (EA 4712), University of Rennes 1, Rennes University Hospital, France., Grandjean D; Neuroscience of Emotion and Affective Dynamics laboratory, Department of Psychology and Swiss Center for Affective Sciences, Campus Biotech, University of Geneva, Switzerland; Swiss Center for Affective Sciences, Campus Biotech, University of Geneva, Switzerland., Péron J; Clinical and Experimental Neuropsychology Laboratory, Department of Psychology and Educational Sciences, University of Geneva, Switzerland; Neuropsychology Unit, Neurology Department, University Hospitals of Geneva, Switzerland. Electronic address: julie.peron@unige.ch.

Publikováno v: NeuroImage [Neuroimage] 2020 Nov 15; Vol. 222, pp. 117215. Date of Electronic Publication: 2020 Aug 01.

Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson's Disease Patients (PSYCHO-STIM).

Autor: Boussac M; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France., Arbus C; Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France., Dupouy J; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Harroch E; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Rousseau V; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Ory-Magne F; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.; Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Rascol O; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France., Moreau C; CHU of Lille, Univ. Lille, Inserm UMRS_1171, Licend, Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's Disease, Lille, France., Maltête D; Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France., Rouaud T; Clinique Neurologique, Hôpital Guillaume et René Laennec, Boulevard Jacques Monod, Nantes Cedex., Meyer M; Neurology Department, Nancy University Hospital, Nancy, France., Houvenaghel JF; Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, Rennes Cedex, France., Marsé C; CHU Nice, Centre Expert Parkinson, Service de Neurologie, Nice, France., Tranchant C; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France., Hainque E; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, Paris, France., Jarraya B; Pôle Neurosciences, Foch Hospital, Suresnes, France; Université de Versailles Paris-Saclay, INSERM U992, CEA Neurospin, Paris, France., Ansquer S; Service de Neurologie, Centre Expert Parkinson, CIC-INSERM 1402, CHU Poitiers, Poitiers, France., Bonnet M; CHU de Bordeaux, Centre Expert Parkinson, Institut des maladies neuro-dégénératives, Bordeaux, France., Belamri L; Hôpital Fondation A de Rothschild, service de recherche clinique, F-75019 Paris, France., Tir M; Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's Disease, Amiens University Hospital, EA 4559 Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP) Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), Amiens, France., Marques AR; Université Clermont Auvergne, EA7280, Clermont-Ferrand University Hospital, Neurology Department, Clermont-Ferrand, France., Danaila T; Centre Expert Parkinson, Hôpital Neurologique 'Pierre Wertheimer', Hospices Civils de Lyon, Bron, France., Eusebio A; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS 7289, Institut de Neuroscience de La Timone, Marseille, France., Devos D; CHU of Lille, Univ. Lille, Inserm UMRS_1171, Licend, Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's Disease, Lille, France., Brefel-Courbon C; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.; Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France.

Publikováno v: Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (3), pp. 1057-1066.